-

AIS Healthcare Recognized by Accreditation Commission for Health Care

DALLAS--(BUSINESS WIRE)--AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to announce that it is has been awarded accreditations for Specialty Pharmacy, Infusion Pharmacy, and Infusion Nursing by the Accreditation Commission for Health Care (ACHC), an internationally recognized accrediting body, further setting it apart from other infusion services providers. This accomplishment underscores the company’s commitment to going beyond what’s expected to advance quality care and improve the lives of patients.

Formed in 1986, the Accreditation Commission for Health Care grants accreditation for providers in the home care and home infusion therapy industries. The Commission plays a critical role in ensuring providers deliver quality and effective services to patients. Accreditation also helps providers like AIS Healthcare to demonstrate their ability to meet official regulatory requirements and standards, resulting in a higher level of performance and a greater focus on patient care.

“This accomplishment is a testament to our employees who commit themselves to providing the highest quality care to our patients. We will continue to take the steps necessary to ensure every one of our employees, every process, and every protocol puts patient safety first. Thank you to ACHC for this important recognition and to the entire team at AIS Healthcare for their dedication to the patients we serve,” said Simon Castellanos, AIS Healthcare CEO.

About AIS Healthcare

Advancing quality. Improving lives.

As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.

Learn more at aiscaregroup.com

Contacts

Simon Castellanos
877.443.4006

Industry:

AIS Healthcare

Release Versions
English

Contacts

Simon Castellanos
877.443.4006

More News From AIS Healthcare

Advanced Infusion Care (AIC) Now Offers Kedrion Biopharma’s YIMMUGO® (Immune Globulin Intravenous Human-Dira, 10% Liquid)

DALLAS--(BUSINESS WIRE)--AIC, a division of AIS Healthcare, now offers YIMMUGO®, manufactured by Kedrion Biopharma, for the treatment of primary humoral immunodeficiency in patients 2 years of age and older. Approved by the U.S. Food and Drug Administration in June 2024, YIMMUGO® is now available at all AIC locations. The nationally accredited infusion teams at AIC collaborate closely with physicians to provide specialized infusion services to patients in their home or in an infusion center set...

Advanced Infusion Care Expands National Footprint by Launching a New Outpatient Infusion Center in Phoenix, AZ

DALLAS--(BUSINESS WIRE)--Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of patient-specific infusion therapy, proudly announces the launch of Advanced Infusion Care Centers (AICC), with the opening of its first location in Phoenix, AZ. This new center marks a major milestone in AIC’s continued growth and its mission to expand access to compassionate, high quality infusion care nationwide. The creation of AICC reflects the company’s strategic commitment to meet...

AIS Healthcare Acquires Preferred Excellent Care in Garden Grove, CA

DALLAS--(BUSINESS WIRE)--Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of patient-specific infusion therapy, has announced the acquisition of Preferred Excellent Care (“PEC”), a California-based pharmacy focused on infusion medications and services. PEC’s pharmacy in Garden Grove, CA is AIC’s sixth location from which the company will dispense essential medications and personalized care to patients across the United States with complex medical conditions like...
Back to Newsroom